Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Reckitt Deals Feed OTC Domination Plan

This article was originally published in The Tan Sheet

Executive Summary

Reckitt Benckiser CEO Rakesh Kapoor plays up the firm’s potential to dominate the fragmented global consumer health product market and says Reckitt is better positioned than big pharma firms to manage OTC businesses. Reckitt continued its emerging markets focus with OTC deals in Latin America and China.

Advertisement

Related Content

Bristol-Myers Squibb Sells French Consumer Health Unit UPSA To Taisho For $1.6bn
European OTC Shifts: BMS Eyes Selling French Business, Private Equity Controls Italy's Recordati
European OTC Shifts: BMS Eyes Selling French Business, Private Equity Controls Italy's Recordati
Probiotics Space Ripe For M&A, Kline Analyst Says
Major OTC Acquisitions, Expansion Likely In 2014
Sales & Earnings In Brief
Reckitt’s Schiff Buy Reflects Nutritional Industry “On Fire”
Reckitt Reorganizes To Develop Health Care, Emerging Markets
Reckitt CEO Becht’s Exit Has Analysts Expecting Bumps Ahead
BMS Divests Indonesian OTC Business, Continues Biopharma Consolidation

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS106236

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel